While disorders like schizophrenia are characterised by a wide spectrum of genetic variation including a high burden of rare variants [13], others may be characterised by common variants of stronger effect in genes such as LRRK2 in Parkinson’s disease (PD), or APOE in Alzheimer’s disease (AD). This evidence concerns the gene APOE and Alzheimer disease.